STAAR Surgical STAA +24.21% stock surged more than 25% on Thursday after the ophthalmic implant maker projected first-quarter net sales would top $90 million, more than double the year-ago period.
The company attributed the sharp increase largely to a recovery in China, where distributor inventory reductions had weighed on results last year. STAAR Surgical stock also benefited from continued double-digit expansion in the Americas region. STAAR Surgical stock saw improved operating leverage and cost management that are expected to lift adjusted EBITDA meaningfully.
Management noted that the sales rebound in China was accompanied by steady demand across the Americas portfolio. STAAR Surgical stock moved higher even as executives acknowledged lingering pressure from geopolitical tensions and uneven economic conditions in parts of the Middle East, Europe, and Asia-Pacific.
https://www.gurufocus.com/news/8785319/staar-surgical-shares-jump-25-on-blowout-90m-sales-outlook
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.